https://www.thebodypro.com/author/pfizer

Pfizer, Inc.

Latest by Pfizer, Inc.

Promo Image
News

Case Study of a Patient With Serious Hepatotoxicity in Maraviroc 2b/3 Trial Reported at Targeting HIV Entry -- 1st International Workshop

Bethesda, MD -- Howard Mayer, M.D. of Pfizer Global Research and Development presented today on a case of one patient with serious hepatotoxicity in the treatment naïve trial of the maraviroc phase 2b/3 program. Speaking at the "Targeting HIV Entry -...

By Pfizer, Inc.
Promo Image

Pfizer Discontinues Development of Capravirine, for HIV/AIDS

New London, CT -- Pfizer Inc. said today that it has discontinued clinical development on capravirine, a phase 2 HIV/AIDS drug in a class known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Pfizer has been developing capravirine for pa...

By Pfizer, Inc.
Promo Image
News

New Nelfinavir Formulation Now Available for Patients With HIV

WHAT: Pfizer Inc. today announced that the 625 mg formulation of the protease inhibitor, VIRACEPT® (nelfinavir mesylate) is now available. VIRACEPT, in combination with other antiretroviral agents, is indicated for the treatment of HIV infection. Pfi...

By Pfizer, Inc.